SUZANNE MAINS: Open Payments
NPI 1619261542 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 54 payments from 16 companies in 2025. Trend: 2023 $1,079 · 2024 $1,252 · 2025 $1,546
Food & beverage: $1,546
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $312 |
| Janssen Biotech, Inc. | 8 | $293 |
| Boston Scientific Corporation | 3 | $160 |
| Astellas Pharma US Inc | 4 | $122 |
| ABBVIE INC. | 5 | $112 |
| Antares Pharma, Inc. | 4 | $95 |
| Alnylam Pharmaceuticals Inc. | 4 | $83 |
| 180 Medical, Inc. | 2 | $57 |
| Endo USA, Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $50 |
Products named: GEMTESA, ERLEADA, RYBREVANT, Xtandi, AMS 700, XYOSTED, GIVLAARI, BOTOX.
Industry payments across NY — which companies pay providers there.
